Enveric Biosciences (ENVB) Stock Chart & Stock Price History $1.34 +0.03 (+1.91%) As of 03:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enveric Biosciences Stock Price Performance The Enveric Biosciences (ENVB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 82.76%, with a year-to-date return of -75.17%. In the past month, the stock has increased 10.33%, reflecting recent market activity. As of the latest close, Enveric Biosciences traded at $1.31 with a market cap of $3.24 million and volume of 61,224 shares. Receive ENVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.11%1 Month Performance+10.33%3 Month Performance+5.12%Year-To-Date Performance-75.17%1 Year Performance-82.76% ENVB Stock Chart for Monday, July, 14, 2025 ENVB Chart by TradingView Enveric Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$1.35$1.31-2.96%$1.36$1.3161,224 shs$3.24 million07/10/2025$1.35$1.35$1.36$1.3192,726 shs$3.34 million07/09/2025$1.29$1.35+4.65%$1.35$1.2885,173 shs$3.33 million07/08/2025$1.27$1.29+1.57%$1.31$1.2654,549 shs$3.19 million07/07/2025$1.26$1.27+1.20%$1.28$1.2540,841 shs$3.14 million07/04/2025$1.26$1.26$1.28$1.2435,571 shs$3.10 million07/03/2025$1.25$1.26+0.40%$1.28$1.2435,571 shs$3.10 million07/02/2025$1.23$1.25+1.63%$1.26$1.2334,676 shs$3.09 million07/01/2025$1.21$1.23+1.65%$1.25$1.2067,012 shs$3.04 million06/30/2025$1.24$1.21-2.42%$1.25$1.19118,424 shs$2.99 million Get the Latest News and Ratings for ENVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$1.27$1.24-2.36%$1.32$1.23467,769 shs$3.06 million06/26/2025$1.24$1.27+2.42%$1.28$1.2255,696 shs$3.14 million06/25/2025$1.25$1.24-0.80%$1.27$1.2261,018 shs$3.06 million06/24/2025$1.25$1.25$1.35$1.20305,165 shs$3.09 million06/23/2025$1.27$1.25-1.57%$1.30$1.2159,191 shs$3.09 million06/20/2025$1.26$1.27+0.79%$1.31$1.26101,067 shs$3.14 million06/19/2025$1.26$1.26$1.31$1.24125,017 shs$3.12 million06/18/2025$1.25$1.26+0.80%$1.31$1.24125,017 shs$3.11 million06/17/2025$1.27$1.25-1.57%$1.29$1.2365,404 shs$3.09 million06/16/2025$1.21$1.27+4.96%$1.30$1.23129,033 shs$3.14 million06/13/2025$1.24$1.21-2.42%$1.22$1.18100,804 shs$2.99 million Related Companies SONN Stock Price Chart NXTC Stock Price Chart LPTX Stock Price Chart IMCC Stock Price Chart SNPX Stock Price Chart BTAI Stock Price Chart NERV Stock Price Chart PHIO Stock Price Chart BGXX Stock Price Chart EQ Stock Price Chart Receive ENVB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENVB) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENVB Stock Alerts